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Abstract  
Achieving high and equitable childhood immunisation coverage in Africa will not only protect children from disability and premature death, it will also boost productivity, 
reduce poverty and support the economic growth of the continent. Thus, Africa needs innovative and sustainable vaccine advocacy initiatives. One such initiative is the 
African Vaccine-Preventable Diseases Network, formed in 2009. This association of immunisation practitioners, vaccinologists, paediatricians, and infectious disease 
experts provides a platform to advocate for the introduction of newly available vaccines (e.g. 10-valent and 13-valent pneumococcal conjugate and rotavirus vaccines) 
into the Expanded Programme on Immunisation (EPI) as well as increased and equitable coverage for established EPI vaccines. 
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Background 
 
It is already 11 years since the Millennium Development Goals were established and, with just four more years to go until the 2015 deadline for 
achievement, Africa is lagging behind the rest of the world in its commitment to reduce child mortality by two-thirds [1]. Vaccine-preventable 
diseases continue to be a major contributor to child mortality in the continent as a result of limited vaccine introduction and low immunisation 
coverage [2]. Inclusion of newly available vaccines against pneumococcal disease and rotavirus  diarrhoea into the Expanded Programme on 
Immunisation (EPI) in African countries will reinvigorate efforts to achieve full and broad coverage of all available vaccines [2]. Pneumonia and 
diarrhoea remain leading causes of child deaths in Africa, accounting for over one-third of all paediatric deaths due to infectious diseases [1]. 
Newly available 10-valent and 13-valent pneumococcal conjugate vaccines are expected to provide broad protection against invasive pneumococcal 
disease in Africa, covering at least three-quarters of circulating serotypes [3]. In addition, two rotavirus vaccines have been studied in Africa and 
both  vaccines  show  broad  protection  against  disease-causing  serotypes  [4,5].  Despite  a  lower  efficacy  of  these  rotavirus  vaccines  in  Africa 
compared to high-income countries, the number of preventable deaths is higher in Africa due to the exceptionally high levels of morbidity and 
mortality attributable to rotavirus diarrhoea in the continent [4,5]. There is thus a need for sustainable vaccine advocacy initiatives in Africa. One 
such initiative is the African Vaccine-Preventable Diseases (VPD) Network; formed on 30 October 2009 in Johannesburg, South Africa.  
  
  
The African Vaccine-Preventable Diseases Network 
 
The African VPD Network comprises immunisation practitioners, vaccinologists, paediatricians, and infectious disease experts from across sub-
Saharan Africa. The group endeavours to promote awareness of vaccine-preventable diseases as a prominent cause of morbidity and mortality in 
the African continent. The second meeting of the African VPD Network held in November 2010 in Cape Town, South Africa (on the heels of the 
Second World Pneumonia Day), established a framework for vaccine advocacy in Africa that will encourage the introduction of newly available 
vaccines and promote the uptake of existing and underutilised EPI vaccines.  
  
Strategies for improved vaccine advocacy are needed in Africa, based on the knowledge that innovative and sustained activities can bring about 
change [6-9]. The group noted that increasing public awareness is critical for successful vaccine advocacy; as it is only by making vaccine-
preventable  diseases  well  known  to  the  public  that  tackling  them  will  become  a  national  priority  in  each  African  country.  Evidence-based 
information needs to reach all levels of society, from the general public to EPI decision-makers, dispelling any myths and misconceptions, and 
reminding stakeholders that vaccination is a safe and cost-effective health intervention.  
  
  
Conclusion 
 
The positive effects of vaccination are far-reaching [10]. Immunising a nation’s children against diseases not only protects them from disability and 
premature death,  it also boosts productivity, reduces poverty, and supports the economic growth of a country. The African VPD network is 
committed to improving access to vaccines via the development and publication of an advocacy action plan for Africa; identifying and opening 
dialogue with all immunisation stakeholders; and engaging with public figures outside the medical field, such as the media, who can champion the 
cause.  
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